首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   9962篇
  免费   592篇
  国内免费   41篇
耳鼻咽喉   224篇
儿科学   226篇
妇产科学   262篇
基础医学   1327篇
口腔科学   395篇
临床医学   897篇
内科学   2337篇
皮肤病学   197篇
神经病学   888篇
特种医学   172篇
外科学   1899篇
综合类   42篇
预防医学   665篇
眼科学   185篇
药学   490篇
中国医学   40篇
肿瘤学   349篇
  2023年   69篇
  2022年   144篇
  2021年   281篇
  2020年   163篇
  2019年   281篇
  2018年   303篇
  2017年   188篇
  2016年   245篇
  2015年   297篇
  2014年   398篇
  2013年   459篇
  2012年   688篇
  2011年   786篇
  2010年   494篇
  2009年   409篇
  2008年   653篇
  2007年   671篇
  2006年   670篇
  2005年   592篇
  2004年   544篇
  2003年   462篇
  2002年   435篇
  2001年   180篇
  2000年   184篇
  1999年   150篇
  1998年   83篇
  1997年   51篇
  1996年   44篇
  1995年   39篇
  1994年   39篇
  1993年   30篇
  1992年   77篇
  1991年   79篇
  1990年   63篇
  1989年   48篇
  1988年   41篇
  1987年   40篇
  1986年   31篇
  1985年   17篇
  1984年   20篇
  1983年   14篇
  1982年   11篇
  1981年   11篇
  1980年   14篇
  1979年   15篇
  1978年   12篇
  1976年   8篇
  1975年   8篇
  1973年   13篇
  1971年   7篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.

Objectives

To determine the incidence of incisional hernia (IH) in the extraction incision (EI) in colorectal resection for cancer. To analyze whether the location of the incision has any relationship with the incidence of hernias and whether mesh could be useful for prevention in high-risk patients.

Methods

Retrospective review of the colon and rectal surgery database from January 2015 to December 2016. Data were classified into 2 groups, transverse (TI) and midline incision (MI), and the latter was divided into 2 subgroups (mesh [MIM] and suture [MIS]). Patients were classified using the HERNIAscore. Hernias were diagnosed by clinical and/or CT examination.

Results

A total of 182 out of 210 surgical patients were included. After a median follow-up of 13.0 months, 39 IH (21.9%) were detected, 23 of which (13.4%) were in the EI; their frequency was lower in the TI group (3.4%) and in the MIM group (5.9%) than in the MIS group (29.5%; p = 0.007). The probability of developing IH in the MIS group showed an OR = 11.7 (95%CI: 3.3-42.0) compared to the TI group and 4.3 (IC 95%: 1.1-16.3) versus the MIM group.

Conclusions

The location of the incision is relevant to avoid incisional hernias. Transverse incisions should be used as the first option. When a midline incision is needed, a prophylactic mesh could be considered in high risk patients because it is safe and associated with low morbidity.  相似文献   
3.
4.
5.
6.
7.
8.
9.
Purpose:  To evaluate all consecutive patients treated with infliximab for hidradenitis suppurativa (HS).
Patients and methods:  Within 1 year, all consecutive patients seen in our department for HS (1) resistant to usual medical therapies (2) which could not be easily cured by surgery (3) not treated with new medication within 2 months before inclusion were treated intravenously with infliximab (5 mg/kg) without corticosteroids premedication. Four infusions were planned (week 0, week 2, week 6 and week 10) before the interruption of therapy and follow-up. Clinical activity of HS and quality of life of the patients were assessed immediately before the first, the third and the fourth infusions of infliximab.
Results:  Seven patients were included. Five completed the four infusions. Two patients received only three infusions because of severe side effects. The Sartorius score moderately improved with infliximab (mean score at week 0: 94 ± 39, at week 6: 71 ± 38 and at week 10: 83 ± 48). At week 6, patients judged the efficacy of therapy as marked ( n  = 1), moderate ( n  = 4) or null ( n  = 2). At week 10, five patients were evaluated and judged this efficacy as marked ( n  = 2), moderate ( n  = 2) or null ( n  = 1). The mean Skindex-29 score varied from 22 ± 11 (E: 25 ± 9, S: 13 ± 5, F: 28 ± 12) at week 0 to 18 ± 10 (E: 22 ± 8, S: 12 ± 8, F: 22 ± 12) at week 10.
Conclusion:  The efficacy of infliximab in severe HS is partial. More experience is needed before finding a place for infliximab in the therapeutic armamentarium for HS.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号